Tag: Second Preclinical Study

Else Successfully Completes Second Preclinical Study on the Path For FDA Approval of World’s First Whole Plant, Soy-Free Infant Formula

Press Release May 31, 2022

With products for toddlers and kids already in the market, Else has made tremendous progress towards becoming a player in the $80 billion global infant formula market. VANCOUVER, BC, May 31, 2022 – ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) (“Else” […]